Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations

Bioscience, Biotechnology and Biochemistry

Volumn 67, Issue 11, 2003, Pages 2396-2401

  Lee, Jae Jeong ^a   Yi, Ho Young ^a   Yang, Jae Won ^a   Shin, Jun Seop ^a   Kwon, Jai Hyun ^a   Kim, Chan Wha ^a  

^a Korea University   (South Korea)

Author keywords

Diabetes; Insulin; Islet; Pharmacodynamics; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ANIMAL; ARTICLE; CELL SEPARATION; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; KINETICS; MALE; METABOLISM; PANCREAS; PANCREAS ISLET; PATHOLOGY; RAT; SECRETION; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; CELL SEPARATION; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; KINETICS; MALE; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 3242883645     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.67.2396     Document Type: Article

References (25)

1. Kanazawa, Y., Kawakami, M., and Kawano, M., New classification of diabetes by ADA and WHO with special reference to pathogenesis. Nippon Rinsho, 57, 551-555 (1999).
2. Puavilai, G., Chanprasertyotin, S., and Sriphrapradaeng, A., Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the expert committee on the diagnosis and classification of diabetes mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. Diabetes Res. Clin. Pract., 44, 21-26 (1999).
3. The committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res. Clin. Pract., 55, 65-85 (2002).
4. Atkinson, M. A., and Maclaren, N. K., What causes diabetes? Sci. Am., 263, 62-63 and 66-71 (1990).
5. Thomas, W. H. K., Helen, E. T., Leonard, C. H., and Janette, A., The beta cell in autoimmune diabetes: many mechanisms and pathways of loss. Trends Endocrinol. Metab., 11, 11-15 (2000).
6. Thomas, J. M., Contreras, J. L., Smyth, C. A., Lobashevsky, A., Jenkins, S., Hubbard, W. J., Eckhoff, D. E., Stavrou, S., Neville, D. M. Jr., and Thomas, F. T., Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes. Diabetes, 50, 1227-1236 (2001).
7. Kahn, C. R., Causes of insulin resistance. Nature, 373, 384-385 (1995).
8. Shaw, J. E., Zimmet, P. Z., McCarty, D., and Courten, M., Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care, 23 (Suppl. 2), B5-10 (2000).
9. Birnbaum, M. J., Dialogue between muscle and fat. Nature, 409, 672-673 (2001).
10. Chang, Y. S., Park, W. S., Ko, S. Y., Kang, M. J., Han, J. M., Lee, M. Y., and Choi, J. H., Effects of fasting and insulin-induced hypoglycemia on brain cell membrane function and energy metabolism during hypoxia-ischemia in newborn piglets. Brain Res., 844, 135-142 (1999).
11. Coppey, L. J., Gellett, J. S., Davidson, E. P., Dunlap, J. A., Lund, D. D., and Yorek, M. A., Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes, 50, 1927-1937 (2001).
12. Mikio, I., Yoichi, K., Akiko, N., Koji, H., and Atsuhiko, N., Characterization of low dose streptozotocin-induced progressive diabetes in mice. Environ. Toxicol. Pharmacol., 9, 71-78 (2001).
13. Burg, van der M. P. M., Scheringa, M., Basir, I., and Bouwman, E., Assessment of isolated islet equivalents. Transplant. Proc., 29, 1971-1973 (1997).
14. Brandhorst, H., Brandhorst, D., Brendel, M. D., Hering, B. J., and Bretzel, R. G., Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant., 7, 489-495 (1998).
15. Miyamoto, M., Inoue, K., Gu, Y., Thein, T., Cui, W., Fujiwara, I., Ohyanagi, H., Hayashi, H., Yamazaki, T., Setoyama, H., Kawakami, Y., Ida, J., Kogire, M., Imamura, M., Iwata, H., and Ikada, Y., Improved large-scale isolation of breeder porcine islets: possibility of harvesting from nonheart-beating donor. Cell Transplant., 7, 397-402 (1998).
16. Hardikar, A. A., and Bhonde, R. R., Modulating experimental diabetes by treatment with cytosolic extract from the regenerating pancreas. Diabetes Res. Clin. Pract., 46, 203-211 (1999).
17. Guthrie, R., Is there a need for a better basal insulin? Clinical diabetes, 19, 66-70 (2001).
18. Movassat, J., Saulnier, C., and Portha, B., Insulin administration enhances growth of the beta-cell mass in streptozotocin-treated newborn rats. Diabetes, 46, 1445-1452 (1997).
19. Sakr, F. M., The pharmacokinetics of pulmonary nebulized insulin and its effect on glucose tolerance in streptozotocin-induced diabetic rabbits. Int. J. Pharm., 128, 215-222 (1996).
20. Kawashima, Y., Yamamoto, H., Takeuchi, H., Fujioka, S., and Hino, T., Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J. Control. Release, 62, 279-287 (1999).
21. Kaku, K., Matsuda, M., Urae, A., and Irie, S., Pharmacokinetics and pharmacodynamics of insulin aspart, a rapid-acting analog of human insulin, in healthy Japanese volunteers. Diabetes Res. Clin. Pract., 49, 119-126 (2000).
22. Jeyanthi, R., Thanoo, B. C., Metha, R. C., and Deluca, P. P., Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery. J. Control. Release, 38, 235-244 (1996).
23. Jonas, J. C., Sharma, A., Hasenkamp, W., Ilkova, H., Patanè, G., Laybutt, R., Bonner-Weir, S., and Weir, G. C., Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J. Biol. Chem., 74, 14112-14121 (1999).
24. Pushparaj, P. N., Tan, B. K. H., and Tan, C. H., The mechanism of hypoglycemic action of the semi-purified fractions of Averrhoa bilimbi in streptozotocin-diabetic rats. Life Sci., 70, 535-547 (2001).
25. Saeed, A., Sidney, A. J., Frank, Q. N., and Mary, C. G., A fasting-induced decrease in plasma glucose concentration does not affect the insulin response to ingested protein in people with type 2 diabetes. Metabolism, 51, 1027-1033 (2002).